Zacks.com on MSN7h
TNDM Stock Likely to Gain From Innovation Amid CompetitionTandem Diabetes TNDM is gaining from continued product innovations. Yet, ongoing macroeconomic challenges and tough ...
Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.
The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...
Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.
More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
Arkansas and biotech industry leaders?today announced the launch of the Biotech Entrepreneur Training Program. The training program is ...
2-Year U.S. Treasury Note Continuous Contract $104.441 0.027 0.03% 5-Year U.S. Treasury Note Continuous Contract $110.719 0.055 0.05% 10-Year U.S. Treasury Note Continuous Contract $115.563 0.141 ...
2-Year U.S. Treasury Note Continuous Contract $104.367 0.016 0.01% 5-Year U.S. Treasury Note Continuous Contract $110.305-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $114.766-0.078 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback